Value through Innovation27 July 2016

What is a lay summary?

To view this video in other translations click on the language below:
Chinese (simplified)
Chinese (traditional)
French
German
Italian
Japanese
Portuguese (Brazilian)
Spanish

Clinical Study Results

  • VARGATEF ® - Genital Neoplasms, Female
    Clinical Study Number 1199.6
    Study Indication Genital Neoplasms, Female
    Product VARGATEF ®
    Generic Name Nintedanib
    Lab Code
    Clinical Phase I
    Study Title

    Phase I trial of escalating doses of BIBF 1120 in combination with paclitaxel/carboplatin in patients with advanced gynaecological malignancies

    Study Document
    Trial synopsis 1199.6 english